256 related articles for article (PubMed ID: 2030319)
1. The chemotherapy of leprosy. Part 2.
Ellard GA
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319
[No Abstract] [Full Text] [Related]
2. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
Almeida JG
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
[No Abstract] [Full Text] [Related]
3. Prospects for chemotherapy of leprosy.
Ji B
Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
[No Abstract] [Full Text] [Related]
4. Progress in the chemotherapy of leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
[No Abstract] [Full Text] [Related]
5. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
6. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
7. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
8. Dormancy, drug resistance or dependency; some thoughts to ponder.
Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
[No Abstract] [Full Text] [Related]
9. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
10. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
Waters MF; Pearson JM; Rees RJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
[No Abstract] [Full Text] [Related]
11. Multi-drug therapy in leprosy.
Girdhar BK
Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
[No Abstract] [Full Text] [Related]
12. Problems of multidrug therapy.
Ramu G
Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
[No Abstract] [Full Text] [Related]
13. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333
[No Abstract] [Full Text] [Related]
14. New developments in the chemotherapy of leprosy.
Freerksen E
Lepr India; 1983 Jan; 55(1):122-32. PubMed ID: 6348410
[No Abstract] [Full Text] [Related]
15. Does dapsone resistance really matter in the MDT era?
Ji B
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
[No Abstract] [Full Text] [Related]
16. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
17. The activity of rifabutin against Mycobacterium leprae.
Yoder LJ; Jacobson RR; Hastings RC
Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
[TBL] [Abstract][Full Text] [Related]
18. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
Sreevatsa ; Girdhar BK; Desikan KV
Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
[No Abstract] [Full Text] [Related]
19. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
[No Abstract] [Full Text] [Related]
20. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
